Immunosuppression and the Risk of Post-Transplant Malignancy Among Cadaveric First Kidney Transplant Recipients
dc.contributor.author | Bustami, Rami T. | en_US |
dc.contributor.author | Ojo, Akinlolu O. | en_US |
dc.contributor.author | Wolfe, Robert A. | en_US |
dc.contributor.author | Merion, Robert M. | en_US |
dc.contributor.author | Bennett, William M. | en_US |
dc.contributor.author | McDiarmid, Suzanne V. | en_US |
dc.contributor.author | Leichtman, Alan B. | en_US |
dc.contributor.author | Held, Philip J. | en_US |
dc.contributor.author | Port, Friedrich K. | en_US |
dc.date.accessioned | 2010-06-01T20:30:29Z | |
dc.date.available | 2010-06-01T20:30:29Z | |
dc.date.issued | 2004-01 | en_US |
dc.identifier.citation | Bustami, Rami T.; Ojo, Akinlolu O.; Wolfe, Robert A.; Merion, Robert M.; Bennett, William M.; McDiarmid, Suzanne V.; Leichtman, Alan B.; Held, Philip J.; Port, Friedrich K. (2004). "Immunosuppression and the Risk of Post-Transplant Malignancy Among Cadaveric First Kidney Transplant Recipients." American Journal of Transplantation 4(1): 87-93. <http://hdl.handle.net/2027.42/73619> | en_US |
dc.identifier.issn | 1600-6135 | en_US |
dc.identifier.issn | 1600-6143 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/73619 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=14678038&dopt=citation | en_US |
dc.format.extent | 105219 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Munksgaard International Publishers | en_US |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | Blackwell Munksgaard 2003 | en_US |
dc.subject.other | Antilymphocyte Antibodies | en_US |
dc.subject.other | Cadaveric Kidney Transplantation | en_US |
dc.subject.other | De Novo Tumors | en_US |
dc.subject.other | Immunosuppression | en_US |
dc.subject.other | Induction Therapy | en_US |
dc.subject.other | PTLD | en_US |
dc.subject.other | Risk Factors | en_US |
dc.title | Immunosuppression and the Risk of Post-Transplant Malignancy Among Cadaveric First Kidney Transplant Recipients | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Medicine (General) | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Scientific Registry of Transplant Recipients/University of Michigan Kidney Epidemiology and Cost Center, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Department of Veterans Affairs Medical Center, Division of Nephrology, University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Division of Transplantation, Department of Surgery, University of Michigan Health System, Ann Arbor, MI | en_US |
dc.contributor.affiliationother | Scientific Registry of Transplant Recipients/University Renal Research and Education Association, Ann Arbor, MI | en_US |
dc.contributor.affiliationother | Solid Organ and Cellular Transplantation, Legacy Good Samaritan Hospital, and Northwest Renal Clinic, Portland, OR | en_US |
dc.contributor.affiliationother | Pediatric Liver Transplantation, Department of Pediatrics and Surgery, UCLA Medical Center, Los Angeles, CA | en_US |
dc.identifier.pmid | 14678038 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/73619/1/j.1600-6135.2003.00274.x.pdf | |
dc.identifier.doi | 10.1046/j.1600-6135.2003.00274.x | en_US |
dc.identifier.source | American Journal of Transplantation | en_US |
dc.identifier.citedreference | Kew CE 2nd, Lopez-Ben R, Smith JK et al. Posttransplant lymphoproliferative disorder localized near the allograft in renal transplantation. Transplantation 2000; 69: 809 – 814. | en_US |
dc.identifier.citedreference | Winkelhorst JT, Brokelman WJ, Tiggeler RG, Wobbes T. Incidence and clinical course of de-novo malignancies in renal allograft recipients. Eur J Surg Oncol 2001; 27: 409 – 413. | en_US |
dc.identifier.citedreference | Ondrus D, Pribylincova V, Breza J et al. The incidence of tumours in renal transplant recipients with long-term immunosuppressive therapy. Int Urol Nephrol 1999; 31: 417 – 422. | en_US |
dc.identifier.citedreference | Jain AB, Yee LD, Nalesnik MA et al. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 1998; 66: 1193 – 1200. | en_US |
dc.identifier.citedreference | Penn I. Posttransplantation de novo tumors in liver allograft recipients. Liver Transpl Surg 1996; 2: 52 – 59. | en_US |
dc.identifier.citedreference | Mihalov ML, Gattuso P, Abraham K et al. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center. Clin Transplant 1996; 10: 248 – 255. | en_US |
dc.identifier.citedreference | Barrett WL, First MR, Aron BS, Penn I. Clinical course of malignancies in renal transplant recipients. Cancer 1993; 72: 2186 – 2189. | en_US |
dc.identifier.citedreference | 8. National Kidney Federation. Cancer after kidney transplantation. Available at: http://www.kidney.org.uk/Medical-Info/transplant/txcancer.html. Accessed May 7, 2003. | en_US |
dc.identifier.citedreference | Libertiny G, Watson CJ, Gray DW et al. Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients. Br J Surg 2001; 88: 1330 – 1334. | en_US |
dc.identifier.citedreference | Angel LF, Cai TH, Sako EY, Levine SM. Posttransplant lymphoproliferative disorders in lung transplant recipients: clinical experience at a single center. Ann Transplant 2000; 5: 26 – 30. | en_US |
dc.identifier.citedreference | Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 1993; 342: 1514 – 1516. | en_US |
dc.identifier.citedreference | Holmes RD, Sokol RJ. Epstein-Barr virus and post-transplant lymphoproliferative disease. Pediatr Transplant 2002; 6: 456 – 464. | en_US |
dc.identifier.citedreference | Winter P, Schoeneich G, Miersch WD, Klehr HU. Tumour induction as a consequence of immunosuppression after renal transplantation. Int Urol Nephrol 1997; 29: 701 – 709. | en_US |
dc.identifier.citedreference | Younes BS, McDiarmid SV, Martin MG et al. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients. Transplantation 2000; 70: 94 – 99. | en_US |
dc.identifier.citedreference | Jamil B, Nicholls K, Becker GJ, Walker RG. Impact of acute rejection therapy on infections and malignancies in renal transplant recipients. Transplantation 1999; 68: 1597 – 1603. | en_US |
dc.identifier.citedreference | 16. U.S. Renal Data System. USRDS 1998 Annual Data Report. Bethesda, MD: National Institutes of Health. National Institute of Diabetes and Digestive and Kidney Diseases, 1998. | en_US |
dc.identifier.citedreference | Melosky B, Karim M, Chui A et al. Lymphoproliferative disorders after renal transplantation in patients receiving triple or quadruple immunosuppression. J Am Soc Nephrol 1992; 2: S290 – S294. | en_US |
dc.identifier.citedreference | Meier-Kriesche HU, Arndorfer JA, Kaplan B. Association of antibody induction with short- and long-term cause-specific mortality in renal transplant recipients. J Am Soc Nephrol 2002; 13: 769 – 772. | en_US |
dc.identifier.citedreference | 19. 2002 OPTN/SRTR Annual Report 1991–2001. HHS/HRSA/OSP/DOT; UNOS; URREA. | en_US |
dc.identifier.citedreference | Dickinson DM, Ellison MD, Webb RL. SRTR Report on the State of Transplantation: data sources and structure. Am J Transplant 2003; 3: 13 – 28. | en_US |
dc.identifier.citedreference | Bates WD, Gray DW, Dada MA et al. Lymphoproliferative disorders in Oxford renal transplant recipients. J Clin Pathol 2003; 56: 439 – 446. | en_US |
dc.identifier.citedreference | Dharnidharka VR, Sullivan EK, Stablein DM et al. North American Pediatric Renal Transplant Cooperative Study: Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation 2001; 71: 1065 – 1068. | en_US |
dc.identifier.citedreference | Cockfield SM. Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transpl Infect Dis 2001; 3: 70 – 78. | en_US |
dc.identifier.citedreference | Montagnino G, Lorca E, Tarantino A et al. Cancer incidence in 854 kidney transplant recipients from a single institution: comparison with normal population and with patients under dialytic treatment. Clin Transplant 1996; 10: 461 – 469. | en_US |
dc.identifier.citedreference | Holmes RD, Orban-Eller K, Karrer FR et al. Response of elevated Epstein-Barr virus DNA levels to therapeutic changes in pediatric liver transplant patients: 56-month follow up and outcome. Transplantation 2002; 74: 367 – 372. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.